Wednesday, December 17, 2003

The United States Conference of Catholic Bishops (USCCB)

The federal Nonprescription Drugs Advisory Committee and the Advisory Committee for Reproductive Health Drugs voted yesterday to approve a proposal to make Plan B, a levonorgestrel-only "morning after pill," available without a prescription. The final decision rests with the Food and Drug Administration. The United States Conference of Catholic Bishops (USCCB) filed written comments against the proposal. "A drug which destroys human embryos and puts women at greater risk of ectopic pregnancy does not belong on the shelves of a drug store," said Cathy Cleaver Ruse, Director of Planning and Information for the USCCB Secretariat for Pro-Life Activities. "American women and children do not deserve this reckless experiment on their lives." Source: USCCB